These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 710513

  • 1. Nucleus accumbens lesions reduce amphetamine hyperthermia but not hyperactivity.
    Wirtshafter D, Asin KE, Kent EW.
    Eur J Pharmacol; 1978 Oct 15; 51(4):449-52. PubMed ID: 710513
    [Abstract] [Full Text] [Related]

  • 2. Septal lesions enhance hyperactivity induced either by amphetamine or lesions of the nucleus accumbens septi.
    Carey RJ.
    Behav Brain Res; 1982 May 15; 5(1):43-52. PubMed ID: 7082466
    [Abstract] [Full Text] [Related]

  • 3. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
    Kelly PH, Roberts DC.
    Pharmacol Biochem Behav; 1983 Jul 15; 19(1):137-43. PubMed ID: 6413984
    [Abstract] [Full Text] [Related]

  • 4. The effects of radio-frequency lesions of the nucleus accumbens on d-amphetamine-induced locomotor and rearing behavior in rats.
    Kehne JH, Sant WW, Sorenson CA.
    Psychopharmacology (Berl); 1981 Jul 15; 75(4):363-7. PubMed ID: 6803281
    [Abstract] [Full Text] [Related]

  • 5. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ, Rankin J.
    Behav Neurosci; 1989 Aug 15; 103(4):831-6. PubMed ID: 2765186
    [Abstract] [Full Text] [Related]

  • 6. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants.
    French ED, Vantini G.
    Psychopharmacology (Berl); 1984 Aug 15; 82(1-2):83-8. PubMed ID: 6141586
    [Abstract] [Full Text] [Related]

  • 7. Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation.
    Olds ME.
    Neuroscience; 1990 Aug 15; 35(2):313-25. PubMed ID: 2199840
    [Abstract] [Full Text] [Related]

  • 8. Interaction of dopamine agonists with disrupted mesolimbic pathways implications for mental health.
    Wray SR, Melville GN, Wenger T, Louden D.
    West Indian Med J; 1984 Jun 15; 33(2):106-16. PubMed ID: 6541399
    [No Abstract] [Full Text] [Related]

  • 9. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.
    Brudzyński SM, Mogenson GJ.
    Brain Res; 1985 May 13; 334(1):77-84. PubMed ID: 2986781
    [Abstract] [Full Text] [Related]

  • 10. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.
    Kafetzopoulos E.
    Psychopharmacology (Berl); 1986 May 13; 88(3):271-4. PubMed ID: 3083447
    [Abstract] [Full Text] [Related]

  • 11. The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.
    Maj J, Wedzony K.
    Eur J Pharmacol; 1988 Jan 12; 145(2):97-103. PubMed ID: 3350045
    [Abstract] [Full Text] [Related]

  • 12. Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat.
    Van den Bos R, Cools AR, Ogren SO.
    Acta Physiol Scand; 1990 Mar 12; 138(3):423-4. PubMed ID: 2158210
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of drug-induced circling by GABA-ergic activity in the nucleus accumbens.
    Hartgraves SL, Kelly PH.
    Brain Res Bull; 1983 Sep 12; 11(3):315-20. PubMed ID: 6640362
    [Abstract] [Full Text] [Related]

  • 14. Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to D-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens.
    Simon H, Taghzouti K, Gozlan H, Studler JM, Louilot A, Herve D, Glowinski J, Tassin JP, Le Moal M.
    Brain Res; 1988 May 03; 447(2):335-40. PubMed ID: 3134111
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus.
    Wilkinson LS, Mittleman G, Torres E, Humby T, Hall FS, Robbins TW.
    Behav Brain Res; 1993 Jun 30; 55(2):143-50. PubMed ID: 8395178
    [Abstract] [Full Text] [Related]

  • 16. Hyperactivity response to apomorphine and amphetamine in the mouse: the importance of the nucleus accumbens and caudate-putamen.
    Costall B, Naylor RJ, Nohria V.
    J Pharm Pharmacol; 1979 Apr 30; 31(4):259-61. PubMed ID: 36471
    [No Abstract] [Full Text] [Related]

  • 17. Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats?
    Robinson TE, Camp DM.
    Neuropsychopharmacology; 1990 Jun 30; 3(3):163-73. PubMed ID: 1694669
    [Abstract] [Full Text] [Related]

  • 18. Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration.
    Lyness WH, Friedle NM, Moore KE.
    Pharmacol Biochem Behav; 1979 Nov 30; 11(5):553-6. PubMed ID: 531077
    [Abstract] [Full Text] [Related]

  • 19. Response of ventral pallidal neurons to amygdala stimulation and its modulation by dopamine projections to nucleus accumbens.
    Yim CY, Mogenson GJ.
    J Neurophysiol; 1983 Jul 30; 50(1):148-61. PubMed ID: 6875644
    [Abstract] [Full Text] [Related]

  • 20. Destruction of 5-hydroxytryptaminergic neurons and the dynamics of dopamine in nucleus accumbens septi and other forebrain regions of the rat.
    Lyness WH, Moore KE.
    Neuropharmacology; 1981 Apr 30; 20(4):327-34. PubMed ID: 6793886
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.